Find out about IMPACT, a partnership between Anthony Nolan, Leuka, NHS Blood and Transplant and the University of Birmingham (UK), which aims to deliver the UK’s first large-scale clinical trials program in this exclusive blog piece.
Browsing: stem cells
A study has demonstrated the inhibitory effects of damsin – found in Ambrosia arborscens – on breast cancer stem cells. Ambrosin, a synthetically produced compound similar to damsin also has the same anti-cancer capabilities.
In this video Chris Lewis describes the best and worst aspects of his care and explains how he would like care for cancer patients improve over the coming years.
A novel ‘labyrinth’ chip is isolating cancer cells from the blood of patients with an aggressive form of breast cancer in a clinical trial.
Chris was diagnosed with lymphoma in 2007, as part of his treatment he received a stem cell transplant – in this video you can discover what it is like to undergo a stem cell transplant and find out how it is performed.
Chris Lewis (Patient Advocate and Founder of Chris’s Cancer Community) discusses the treatment he underwent following…
Chris Lewis (Patient Advocate and Founder of Chris’s Cancer Community) discusses some of the symptoms of lymphoma and the process of his diagnosis in this video interview with our Editor, Jade Parker.
How can policy help improve patient outcomes in stem cell transplantation? An interview with Mark Tami MP
In this interview we explore the policy surrounding stem cell transplantation including high-profile projects such as the Defend Second Transplants campaign and find out ways to diversify the stem cell donor register to ensure that charities such as Anthony Nolan can provide the best donor match to individuals with blood cancer.
Five-year direct costs of acute lymphoblastic leukemia pediatric patients undergoing allogeneic stem cell transplant
Discover the economic burden of allogeneic hematopoietic stem cell transplant in acute lymphoblastic leukemia pediatric patients in this research article from our partnered journal, the International Journal of Hematologic Oncology.
In this interview find out about Anthony Nolan’s research strategy, breakthroughs that have aided the advancement of stem cell transplantation, how third-generation sequencing for HLA typing may improve donor-recipient matching and the direction that Alejandro Madrigal envisions Anthony Nolan’s research will take in the coming years.